BMJ medicine

Keyphrases

Publications

volume 3, number 1, 2024

Lasai Barreñada, Ashleigh Ledger, Paula Dhiman, Gary Stephen Collins, Laure Wynants, Jan Yvan Jos Verbakel, Dirk Timmerman, Lil Valentin, Ben Van Calster
ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies. BMJ medicine 3 (1) (2024)
Thomas Beaney, Jonathan Clarke, Thomas Woodcock, Azeem Majeed, Mauricio Barahona, Paul Aylin
Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study. BMJ medicine 3 (1) (2024)
Lasai Barreñada, Ashleigh Ledger, Paula Dhiman, Gary Stephen Collins, Laure Wynants, Jan Yvan Jos Verbakel, Dirk Timmerman, Lil Valentin, Ben Van Calster
ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies. BMJ medicine 3 (1) (2024)
Jane Elizabeth Harding, Jane M Alsweiler, Taygen E Edwards, Chris Jd McKinlay
Neonatal hypoglycaemia. BMJ medicine 3 (1) (2024)
Rebecca Mary Casey, Hiroki Akaba, Terri B Hyde, Paul Bloem
Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates. BMJ medicine 3 (1) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Sarah Davis, Steve Goodacre, Daniel Edward Horner, Abdullah Pandor, Mark Holland, Kerstin de Wit, Beverley Jane Hunt, Xavier Luke Griffin
Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study. BMJ medicine 3 (1) (2024)
Gaurav Bhaskar Nigam, Michael F Murphy, Simon P L Travis, Adrian J Stanley
Machine learning in the assessment and management of acute gastrointestinal bleeding. BMJ medicine 3 (1) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Dan Yedu Quansah, Leah Gilbert, Amar Arhab, Elena Gonzalez-Rodriguez, Didier Hans, Justine Gross, Stefano Lanzi, Bobby Stuijfzand, Alain Lacroix, Antje Horsch, Jardena J Puder
Effect of a prepartum and postpartum, complex interdisciplinary lifestyle and psychosocial intervention on metabolic and mental health outcomes in women with gestational diabetes mellitus (the MySweetheart trial): randomised, single centred, blinded, controlled trial. BMJ medicine 3 (1) (2024)
Anne-Laure Boulesteix, Sabine Hoffmann
To adjust or not to adjust: it is not the tests performed that count, but how they are reported and interpreted. BMJ medicine 3 (1) (2024)
Rebecca Mary Casey, Hiroki Akaba, Terri B Hyde, Paul Bloem
Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates. BMJ medicine 3 (1) (2024)
Shalini Santhakumaran, Louis Fisher, Viyaasan Mahalingasivam, Lucy Plumb, Edward P K Parker, Retha Steenkamp, Caroline Morton, Amir Mehrkar, Sebastian Bacon, Sue Lyon, Rob Konstant-Hambling, Alex J Walker, Brian MacKenna, Laurie A Tomlinson, Dorothea Nitsch
Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry. BMJ medicine 3 (1) (2024)
Saketh R Guntupalli
Practical implications of the ADNEX risk prediction model for diagnosis of ovarian cancer. BMJ medicine 3 (1) (2024)
Laura Goodfellow, Angharad Care, Ciara Curran, Devender Roberts, Mark A Turner, Marian Knight, Alfirevic Zarko
Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study. BMJ medicine 3 (1) (2024)
Anna Head, Martin O'Flaherty, Chris Kypridemos
Multimorbidity research: where one size does not fit all. BMJ medicine 3 (1) (2024)
Thomas Beaney, Jonathan Clarke, Thomas Woodcock, Azeem Majeed, Mauricio Barahona, Paul Aylin
Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study. BMJ medicine 3 (1) (2024)
Lasai Barreñada, Ashleigh Ledger, Paula Dhiman, Gary Stephen Collins, Laure Wynants, Jan Yvan Jos Verbakel, Dirk Timmerman, Lil Valentin, Ben Van Calster
ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies. BMJ medicine 3 (1) (2024)
Shi Zhao, Wangnan Cao, Gengze Liao, Zihao Guo, Lufei Xu, Chen Shen, Chun Chang, Xiao Liang, Kai Wang, Daihai He, Shengzhi Sun, Rui Chen, Francesca Dominici
All cause and cause specific mortality associated with transition to daylight saving time in US: nationwide, time series, observational study. BMJ medicine 3 (1) (2024)
Dan Yedu Quansah, Leah Gilbert, Amar Arhab, Elena Gonzalez-Rodriguez, Didier Hans, Justine Gross, Stefano Lanzi, Bobby Stuijfzand, Alain Lacroix, Antje Horsch, Jardena J Puder
Effect of a prepartum and postpartum, complex interdisciplinary lifestyle and psychosocial intervention on metabolic and mental health outcomes in women with gestational diabetes mellitus (the MySweetheart trial): randomised, single centred, blinded, controlled trial. BMJ medicine 3 (1) (2024)
Amani Meaidi, Nelsan Pourhadi, Ellen Christine Løkkegaard, Christian Torp-Pedersen, Lina Steinrud Mørch
Association of vaginal oestradiol and the rate of breast cancer in Denmark: registry based, case-control study, nested in a nationwide cohort. BMJ medicine 3 (1) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Thomas Beaney, Jonathan Clarke, Thomas Woodcock, Azeem Majeed, Mauricio Barahona, Paul Aylin
Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study. BMJ medicine 3 (1) (2024)
Nicholas J DeVito, Jessica Morley, James Andrew Smith, Henry Drysdale, Alex J Walker, Carl J Heneghan
Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study. BMJ medicine 3 (1) (2024)
Juan Víctor Ariel Franco, Luis Ignacio Garegnani, Maria-Inti Metzendorf, Katharina Heldt, Rebekka Mumm, Christa Scheidt-Nave
Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies. BMJ medicine 3 (1) (2024)
Shalini Santhakumaran, Louis Fisher, Viyaasan Mahalingasivam, Lucy Plumb, Edward P K Parker, Retha Steenkamp, Caroline Morton, Amir Mehrkar, Sebastian Bacon, Sue Lyon, Rob Konstant-Hambling, Alex J Walker, Brian MacKenna, Laurie A Tomlinson, Dorothea Nitsch
Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry. BMJ medicine 3 (1) (2024)
Nicholas J DeVito, Jessica Morley, James Andrew Smith, Henry Drysdale, Alex J Walker, Carl J Heneghan
Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study. BMJ medicine 3 (1) (2024)
Anne-Laure Boulesteix, Sabine Hoffmann
To adjust or not to adjust: it is not the tests performed that count, but how they are reported and interpreted. BMJ medicine 3 (1) (2024)
Jane Elizabeth Harding, Jane M Alsweiler, Taygen E Edwards, Chris Jd McKinlay
Neonatal hypoglycaemia. BMJ medicine 3 (1) (2024)
Laura Goodfellow, Angharad Care, Ciara Curran, Devender Roberts, Mark A Turner, Marian Knight, Alfirevic Zarko
Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study. BMJ medicine 3 (1) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Laura Goodfellow, Angharad Care, Ciara Curran, Devender Roberts, Mark A Turner, Marian Knight, Alfirevic Zarko
Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study. BMJ medicine 3 (1) (2024)
Saketh R Guntupalli
Practical implications of the ADNEX risk prediction model for diagnosis of ovarian cancer. BMJ medicine 3 (1) (2024)
Jane Elizabeth Harding, Jane M Alsweiler, Taygen E Edwards, Chris Jd McKinlay
Neonatal hypoglycaemia. BMJ medicine 3 (1) (2024)
Anna Head, Martin O'Flaherty, Chris Kypridemos
Multimorbidity research: where one size does not fit all. BMJ medicine 3 (1) (2024)
Shi Zhao, Wangnan Cao, Gengze Liao, Zihao Guo, Lufei Xu, Chen Shen, Chun Chang, Xiao Liang, Kai Wang, Daihai He, Shengzhi Sun, Rui Chen, Francesca Dominici
All cause and cause specific mortality associated with transition to daylight saving time in US: nationwide, time series, observational study. BMJ medicine 3 (1) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Victoria L Bartlett, Harry Doernberg, Maryam Mooghali, Ravi Gupta, Joshua D Wallach, Kate Nyhan, Kai Chen, Joseph R Ross
Published research on the human health implications of climate change between 2012 and 2021: cross sectional study. BMJ medicine 3 (1) (2024)
Sarah Davis, Steve Goodacre, Daniel Edward Horner, Abdullah Pandor, Mark Holland, Kerstin de Wit, Beverley Jane Hunt, Xavier Luke Griffin
Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study. BMJ medicine 3 (1) (2024)
Gaurav Bhaskar Nigam, Michael F Murphy, Simon P L Travis, Adrian J Stanley
Machine learning in the assessment and management of acute gastrointestinal bleeding. BMJ medicine 3 (1) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Shalini Santhakumaran, Louis Fisher, Viyaasan Mahalingasivam, Lucy Plumb, Edward P K Parker, Retha Steenkamp, Caroline Morton, Amir Mehrkar, Sebastian Bacon, Sue Lyon, Rob Konstant-Hambling, Alex J Walker, Brian MacKenna, Laurie A Tomlinson, Dorothea Nitsch
Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry. BMJ medicine 3 (1) (2024)
Victoria L Bartlett, Harry Doernberg, Maryam Mooghali, Ravi Gupta, Joshua D Wallach, Kate Nyhan, Kai Chen, Joseph R Ross
Published research on the human health implications of climate change between 2012 and 2021: cross sectional study. BMJ medicine 3 (1) (2024)
Victoria L Bartlett, Harry Doernberg, Maryam Mooghali, Ravi Gupta, Joshua D Wallach, Kate Nyhan, Kai Chen, Joseph R Ross
Published research on the human health implications of climate change between 2012 and 2021: cross sectional study. BMJ medicine 3 (1) (2024)
Jennifer Susan Lees, Jamie Crowther, Peter Hanlon, Elaine W Butterly, Sarah H Wild, Frances Mair, Bruce Guthrie, Katie Gillies, Sofia Dias, Nicky J Welton, Vittal Srinivasa Katikireddi, David A McAllister
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data. BMJ medicine 3 (1) (2024)
Jennifer Susan Lees, Jamie Crowther, Peter Hanlon, Elaine W Butterly, Sarah H Wild, Frances Mair, Bruce Guthrie, Katie Gillies, Sofia Dias, Nicky J Welton, Vittal Srinivasa Katikireddi, David A McAllister
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data. BMJ medicine 3 (1) (2024)
Amani Meaidi, Nelsan Pourhadi, Ellen Christine Løkkegaard, Christian Torp-Pedersen, Lina Steinrud Mørch
Association of vaginal oestradiol and the rate of breast cancer in Denmark: registry based, case-control study, nested in a nationwide cohort. BMJ medicine 3 (1) (2024)
Rebecca Mary Casey, Hiroki Akaba, Terri B Hyde, Paul Bloem
Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates. BMJ medicine 3 (1) (2024)
Juan Víctor Ariel Franco, Luis Ignacio Garegnani, Maria-Inti Metzendorf, Katharina Heldt, Rebekka Mumm, Christa Scheidt-Nave
Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies. BMJ medicine 3 (1) (2024)
Nicholas J DeVito, Jessica Morley, James Andrew Smith, Henry Drysdale, Alex J Walker, Carl J Heneghan
Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study. BMJ medicine 3 (1) (2024)